-
Mashup Score: 6Corticosteroids as risk factor for COVID-19-associated pulmonary aspergillosis in intensive care patients - Critical Care - 2 year(s) ago
Purpose Corticosteroids, in particular dexamethasone, are one of the primary treatment options for critically ill COVID-19 patients. However, there are a growing number of cases that involve COVID-19-associated pulmonary aspergillosis (CAPA), and it is unclear whether dexamethasone represents a risk factor for CAPA. Our aim was to investigate a possible association of the recommended…
Source: BioMed CentralCategories: Critical Care, Latest HeadlinesTweet
-
Mashup Score: 1(PDF) Threshold of galactomannan antigenemia positivity for early diagnosis of invasive aspergillosis in neutropenic children - 2 year(s) ago
PDF | Purpose Invasive aspergillosis (IA) is an important cause of morbidity and mortality in immunocompromised patients. Pediatric data on the accuracy… | Find, read and cite all the research you need on ResearchGate
Source: ResearchGateCategories: Hem/Oncs, Latest HeadlinesTweet-
Threshold of #galactomannan antigenemia GA positivity for early diagnosis of invasive #aspergillosis IA in neutropenic children Its sensitive test to diagnose IA at cutoff of ≥0.7 2 consecutive values ≥0.7 increases specificity to 91.0% https://t.co/WqfXklj9ZH
-
-
Mashup Score: 2
A blog about biases in the conduct, interpretation, and application of evidence from clinical trials in medicine
Source: www.medicalevidenceblog.comCategories: Critical Care, Latest HeadlinesTweet-
CANARD: Coronavirus Associated Nonpathogenic Aspergillus Respiratory Disease https://t.co/znoFz1cG4F #COVID #aspergillus #CAPA #IPA #aspergillosis #falsepositive https://t.co/JSEygdvOsw
-
-
Mashup Score: 3Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial - 3 year(s) ago
Posaconazole was non-inferior to voriconazole for all-cause mortality up until day 42 in participants with invasive aspergillosis. Posaconazole was well tolerated, and participants had fewer treatment-related adverse events than in the voriconazole group. This study supports the use of posaconazole as a first-line treatment for the condition.
Source: The LancetCategories: Infectious Disease, Latest HeadlinesTweet-
Link to final paper discussed by Meintjes #ECCMID2021 @TheLancet invasive #aspergillosis treatment https://t.co/T98yWrotDb
-
-
Mashup Score: 0Reply to “Current approach to the diagnosis of allergic bronchopulmonary aspergillosis” - 3 year(s) ago
We thank Türk et al1 for the interest shown in our article.2 Regarding their first question, the prevalence of allergic bronchopulmonary aspergillosis (ABPA) in our study was 19.6% (106 of 542) as assessed by a multidisciplinary team (MDT). We classified our asthmatic subjects as mild-to-moderate (mild intermittent, mild persistent, and moderate persistent) and severe (comprising severe…
Categories: Allergy-Immunology, Latest HeadlinesTweet-
In Current Issue (Free)! Reply to “Current approach to the #diagnosis of #allergic #bronchopulmonary #aspergillosis” https://t.co/hMqvwSNUFH
-
-
Mashup Score: 0
We read the work of Saxena et al1 with great interest. In this study, the authors aimed to compare the diagnostic performance of various criteria used for evaluating allergic bronchopulmonary aspergillosis (ABPA) and found that the International Society for Human and Animal Mycology (ISHAM) criteria were only marginally better than the Rosenberg-Patterson criteria to identify ABPA in patients…
Categories: Allergy-Immunology, Latest HeadlinesTweet-
In Current Issue (Free)! Current approach to the diagnosis of #allergic #bronchopulmonary #aspergillosis https://t.co/saNwjTOt0S
-
-
Mashup Score: 0Wolters Kluwer Health - 3 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable…
Source: journals.lww.comCategories: Critical Care, Latest HeadlinesTweet-
More on: The Extent of #Aspergillosis in #CriticallyIll Patients With #influenza in the #ICU ... : Critical Care Medicine https://t.co/Pw5Wd3E66m
-
-
Mashup Score: 0Biomarkers for the Diagnosis of Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis: A Systematic Review and Meta-Analysis - 3 year(s) ago
Allergic bronchopulmonary aspergillosis (ABPA) is a hypersensitivity reaction to Aspergillus fumigatus and impacts 10% of individuals with cystic fibrosis (CF). A diagnosis of ABPA is challenging to establish in CF owing to overlapping clinical and radiologic features with CF lung disease. Recent studies have identified blood tests, imaging, and other biomarkers that may be useful for diagnosis.
Categories: Allergy-Immunology, Latest HeadlinesTweet-
In Current Issue! #Biomarkers for the Diagnosis of #Allergic #Bronchopulmonary #Aspergillosis in #Cystic #Fibrosis: A Systematic Review and Meta-Analysis https://t.co/o9cGYsJRkh https://t.co/G7IUwZWwoe
-
-
Mashup Score: 2Clinical Guidance for the Diagnosis and Treatment of COVID-19-Associated Pulmonary Aspergillosis - Infectious Disease Advisor - 3 year(s) ago
The ECMM and ISHAM released clinical guidance for managing invasive pulmonary aspergillosis among patients with SARS-CoV-2.
Source: Infectious Disease AdvisorCategories: Infectious Disease, Latest HeadlinesTweet-
The ECMM and ISHAM released clinical guidance for managing invasive pulmonary #aspergillosis among patients with SARS-CoV-2. https://t.co/XlKulrDIFZ
-
-
Mashup Score: 3Biomarkers for the diagnosis of allergic bronchopulmonary aspergillosis in cystic fibrosis: a systematic review and meta-analysis - 3 year(s) ago
Allergic bronchopulmonary aspergillosis (ABPA) is a hypersensitivity reaction to Aspergillus fumigatus and impacts 10% of individuals with cystic fibrosis (CF). A diagnosis of ABPA is challenging to establish in CF due to overlapping clinical and radiologic features with CF lung disease. Recent studies have identified blood tests, imaging, and other biomarkers that may be useful for diagnosis.
Categories: Allergy-Immunology, Latest HeadlinesTweet-
In Press! #Biomarkers for the diagnosis of #allergic #bronchopulmonary #aspergillosis in #cystic #fibrosis: a systematic review and meta-analysis https://t.co/o9cGYsJRkh
-
#CritCare #OpenAccess #COVID19: #dexamethasone is associated with a three times increase in the risk of #pulmonary #aspergillosis https://t.co/wWkM1FEBUv @jlvincen @ISICEM #FOAMed #FOAMcc #BMC #ICU #infection #pandemics #Sars_Cov2 #CAPA #corticosteroid https://t.co/jurYZjzwc4